BRYNN TUCKER: Open Payments
NPI 1891410056 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 41 payments from 16 companies in 2025. Trend: 2023 $227 · 2024 $447 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 5 | $145 |
| Astellas Pharma US Inc | 7 | $139 |
| Sumitomo Pharma America, Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Endo USA, Inc. | 3 | $84 |
| ABBVIE INC. | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Ferring Pharmaceuticals Inc. | 1 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Boston Scientific Corporation | 3 | $32 |
Products named: PROVENGE, Xtandi, PLUVICTO, ORGOVYX, AVEED, BOTOX, GEMTESA, ADSTILADRIN.
Industry payments across FL — which companies pay providers there.
